IPO activity is experiencing a resurgence, particularly in the biotech and healthcare sectors, with Kailera Therapeutics leading with a $625 million debut; however, tech startups remain cautious as they await market conditions and the performance of major players like SpaceX. Despite 79 IPO filings in 2026, many tech companies are hesitant to go public due to high valuations and uncertain market support.
The most actionable insight for you is that while IPO activity is increasing, it's primarily driven by biotech and healthcare sectors, with notable tech companies like SpaceX potentially influencing future tech IPOs. If you're tracking tech startup funding, consider focusing on emerging biotech opportunities or waiting to see how major tech IPOs, like SpaceX, perform as they might set the stage for subsequent tech IPOs.